These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1980470)

  • 1. Reduction in transglutaminase activity associated with tumour metastasis is due to the presence of an inactive form of the enzyme.
    Knight CR; Rees RC; Griffin M
    Biochem Soc Trans; 1990 Aug; 18(4):681-2. PubMed ID: 1980470
    [No Abstract]   [Full Text] [Related]  

  • 2. The existence of an inactive form of transglutaminase within metastasising tumours.
    Knight CR; Rees RC; Elliott BM; Griffin M
    Biochim Biophys Acta; 1990 Jun; 1053(1):13-20. PubMed ID: 1973055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of type IV collagenase and plasminogen activator in a hamster fibrosarcoma by basement membrane components and lung fibroblasts.
    Teale DM; Khidair IA; Potter CW; Rees RC
    Br J Cancer; 1988 May; 57(5):475-80. PubMed ID: 2840108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfection of tissue transglutaminase into a highly malignant hamster fibrosarcoma leads to a reduced incidence of primary tumour growth.
    Johnson TS; Knight CR; el-Alaoui S; Mian S; Rees RC; Gentile V; Davies PJ; Griffin M
    Oncogene; 1994 Oct; 9(10):2935-42. PubMed ID: 7916148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis: a potential role for cytosolic transglutaminase and its importance in tumour progression.
    Knight CR; Rees RC; Griffin M
    Biochim Biophys Acta; 1991 Jun; 1096(4):312-8. PubMed ID: 1676603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in the distribution and activity of transglutaminase during tumour growth and metastasis.
    Barnes RN; Bungay PJ; Elliott BM; Walton PL; Griffin M
    Carcinogenesis; 1985 Mar; 6(3):459-63. PubMed ID: 2858274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of tissue transglutaminase by dexamethasone: its correlation to receptor number and transglutaminase-mediated cell death in a series of malignant hamster fibrosarcomas.
    Johnson TS; Scholfield CI; Parry J; Griffin M
    Biochem J; 1998 Apr; 331 ( Pt 1)(Pt 1):105-12. PubMed ID: 9512467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue transglutaminase in tumour progression: friend or foe?
    Kotsakis P; Griffin M
    Amino Acids; 2007 Aug; 33(2):373-84. PubMed ID: 17581697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type IV collagenase activity of a primary HSV-2-induced hamster fibrosarcoma and its in vivo metastases and in vitro clones.
    Teale DM; Rees RC; Thorgeirsson UP; Liotta LA
    Cancer; 1987 Sep; 60(6):1263-8. PubMed ID: 3040211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. POLYOMA-INDUCED TUMORS DO NOT PRODUCE METASTASES: AN EXPERIMENTAL STUDY IN SYRIAN HAMSTERS.
    HERROLD KM
    Arch Pathol; 1965 Aug; 80():116-22. PubMed ID: 14326434
    [No Abstract]   [Full Text] [Related]  

  • 11. A spontaneous metastasizing fibrosarcoma in the golden hamster (Mesocricetus auratus) with some observations on tumor recurrence and metastasis after transplantation.
    KLEIN M
    J Natl Cancer Inst; 1961 Jun; 26():1381-93. PubMed ID: 13756671
    [No Abstract]   [Full Text] [Related]  

  • 12. Heterogeneity of peritoneal macrophages in hamsters-bearing transplantable melanomas in relation to their transglutaminase.
    Kozłowska K; Cichorek M
    Folia Histochem Cytobiol; 1991; 29(4):141-7. PubMed ID: 1687890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the transglutaminase-mediated large molecular weight polymer from rat liver; its relationship to apoptosis.
    Knight RL; Hand D; Piacentini M; Griffin M
    Eur J Cell Biol; 1993 Feb; 60(1):210-6. PubMed ID: 8096461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of plasminogen activator by a primary HSV-2-induced hamster fibrosarcoma and its in vivo derived sublines.
    Khidair IA; Teale DM; Potter CW; Rees RC
    Cancer; 1986 Apr; 57(8):1522-7. PubMed ID: 3948129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue transglutaminase (TG2) in cancer biology.
    Mangala LS; Mehta K
    Prog Exp Tumor Res; 2005; 38():125-38. PubMed ID: 15746533
    [No Abstract]   [Full Text] [Related]  

  • 16. Tissue transglutaminase is not increased during apoptosis of HT-1080 human fibrosarcoma cells.
    Lim SD; Bae SI; Kim IG; Park SC; Chung SI; Nomizu M; Kleinman HK; Kim WH
    Exp Toxicol Pathol; 1998 Mar; 50(1):79-82. PubMed ID: 9570506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo evaluation of type 2 transglutaminase contribution to the metastasis formation in melanoma.
    Di Giacomo G; Lentini A; Beninati S; Piacentini M; Rodolfo C
    Amino Acids; 2009 Apr; 36(4):717-24. PubMed ID: 18594948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the cytosolic and particulate forms of transglutaminase during chemically induced rat liver carcinogenesis.
    Hand D; Elliott BM; Griffin M
    Biochim Biophys Acta; 1988 Jun; 970(2):137-45. PubMed ID: 2898262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 transglutaminase and cell death.
    Piacentini M; Amendola A; Ciccosanti F; Falasca L; Farrace MG; Mastroberardino PG; Nardacci R; Oliverio S; Piredda L; Rodolfo C; Autuori F
    Prog Exp Tumor Res; 2005; 38():58-74. PubMed ID: 15746529
    [No Abstract]   [Full Text] [Related]  

  • 20. Human epidermal transglutaminase.
    Goldsmith LA
    J Invest Dermatol; 1983 Jun; 80 Suppl():39s-41s. PubMed ID: 6133898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.